Department of Medical Oncology,
Affiliated Jinhua Hospital,
Department of Medical Oncology, Affiliated Jinhua Hospital
Jianfei Fu has not added Biography.
If you are Jianfei Fu and would like to personalize this page please email our Author Liaison for assistance.
Young patients (≤ 35 years old) with colorectal cancer have worse outcomes due to more advanced disease: a 30-year retrospective review.
Medicine Nov, 2014 | Pubmed ID: 25415667
A minor (<50%) signet-ring cell component associated with poor prognosis in colorectal cancer patients: a 26-year retrospective study in China.
PloS one , 2015 | Pubmed ID: 25789685
Synchronous Resectable Metastatic Colorectal Cancer: Lymph Node Involvement Predicts Poor Outcome.
Medicine Jul, 2015 | Pubmed ID: 26222850
Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
Oncotarget Oct, 2016 | Pubmed ID: 27542240
Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
PloS one , 2016 | Pubmed ID: 27760180
Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
Journal of surgical oncology Dec, 2016 | Pubmed ID: 27891617
Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
Oncotarget Jan, 2017 | Pubmed ID: 27903960
Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms.
Gastroenterology research and practice , 2017 | Pubmed ID: 28194176
Real-world impact of non-breast cancer-specific death on overall survival in resectable breast cancer.
Cancer Jul, 2017 | Pubmed ID: 28267199
How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype.
Clinical breast cancer 02, 2018 | Pubmed ID: 28802528
Impact of old age on resectable colorectal cancer outcomes.
PeerJ , 2019 | Pubmed ID: 30792941
Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death.
Journal of breast cancer Mar, 2019 | Pubmed ID: 30941237
Young-onset breast cancer: a poor prognosis only exists in low-risk patients.
Journal of Cancer , 2019 | Pubmed ID: 31289582
De-escalating chemotherapy for stage II colon cancer?
Therapeutic advances in gastroenterology , 2019 | Pubmed ID: 31489031
Identification of core genes and pathways in type 2 diabetes mellitus by bioinformatics analysis.
Molecular medicine reports Sep, 2019 | Pubmed ID: 31524257
p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report.
BMC neurology Mar, 2020 | Pubmed ID: 32126984
Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer.
Frontiers in oncology , 2020 | Pubmed ID: 32626650
The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?
Clinical breast cancer May, 2020 | Pubmed ID: 32653474
Poorer prognosis for neuroendocrine carcinoma than signet ring cell cancer of the colon and rectum (CRC-NEC): a propensity score matching analysis of patients from the Surveillance, Epidemiology, and End Results (SEER) database.
International journal of colorectal disease Apr, 2021 | Pubmed ID: 33415449
A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation.
OncoTargets and therapy , 2021 | Pubmed ID: 33603403
Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer.
Frontiers in cell and developmental biology , 2021 | Pubmed ID: 34055773
The Role of Tumour Metabolism in Cisplatin Resistance.
Frontiers in molecular biosciences , 2021 | Pubmed ID: 34250022
Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
Clinical breast cancer 04, 2022 | Pubmed ID: 34627728
Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer.
International journal of clinical oncology Jul, 2022 | Pubmed ID: 35397755
Metabolomics studies on cachexia in patients with cancer: a scoping review protocol.
BMJ open 04, 2022 | Pubmed ID: 35414542
Specific metabolic response of patient-derived organoids to curcumin of colorectal cancer.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Jul, 2022 | Pubmed ID: 35598460
Inhibition of MAT2A-Related Methionine Metabolism Enhances The Efficacy of Cisplatin on Cisplatin-Resistant Cells in Lung Cancer.
Cell journal Apr, 2022 | Pubmed ID: 35674024
1Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine,
2Institute of Gastroenterology, Zhejiang University,
3Department of Colorectal Surgery, Afiliated Jinhua Hospital, Zhejiang University School of Medicine,
4Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine,
5Department of Hepatobiliary Pancreatic Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine,
6Division of Oncology, Johns Hopkins University School of Medicine
Haiping Lin*,1,3,
Hongjuan Zheng*,2,
Chenyang Ge3,
Lixian Ling2,
Ruihua Yin2,
Qinghua Wang2,
Xia Zhang2,
Shishi Zhou2,
Xiayun Jin2,
Xifeng Xu2,
Jianfei Fu2
1Department of Hepatobiliary Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine,
2Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine,
3Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados